North Jersey Gynecology

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• SemaglutideType not stated
• Wegovy (semaglutide)FDA-approved
• Ozempic (semaglutide)FDA-approved
• Compounded tirzepatideCompounded · not FDA-approved

What they publish

North Jersey Gynecology publishes 4 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

None — this is a medical practice billing per visit (as published)

Medication cost

For insured patients, states the visit and medication are covered by insurance. For self-pay patients, published at $200 for the visit plus $200 for the medication. Publishes brand-name comparisons of approximately $1,200-$1,500 per month for Wegovy and $900-$1,200 for Ozempic without insurance (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States that for insured patients both the visit and the medication are covered, with a detailed breakdown of pricing options given at a free consultation.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Free consultation with a detailed pricing breakdown, within a gynaecology practice led by a board-certified obstetrician and gynaecologist who holds Menopause Society Certified Practitioner status.

Eligibility

Clinical criteria such as a BMI threshold were not published on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Cancellation terms were not published on the pages we captured.

Refunds

Refund terms were not published on the pages we captured.

What stands out

• Publishes both the insured and the self-pay position in plain figures — $200 for the visit and $200 for the medication if paying cash. Very little in this directory states an insured pathway at all, let alone alongside a cash price.
• Led by a board-certified OB-GYN who is also a Menopause Society Certified Practitioner, which is the relevant credential where midlife weight change is entangled with hormonal change.
• States plainly on its tirzepatide page that compounded tirzepatide is not FDA-approved and should only be used under a qualified provider's guidance — accurate, and not softened.
• Publishes realistic brand-name cost ranges without insurance and distinguishes the diabetes indication from the weight indication.
• Offers a free consultation before any charge.
• Describes semaglutide as FDA-approved on its semaglutide page while also offering a compounded tirzepatide, so which product an individual patient receives needs establishing directly.
• No clinical criteria, lab requirement, refund or cancellation terms are published.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• If you are insured, what will your plan actually leave you paying after deductible and coinsurance?
• Is the semaglutide the branded product or a compounded preparation? The pages describe both categories.
• Is the $200 medication charge per month, and does it change with dose?
• What clinical criteria apply, and is lab work required first?
• No refund or cancellation terms are published.

Frequently asked